DGAP-News: True Leaf Medicine International Ltd

DGAP-News: True Leaf Establishes European Subsidiary True Leaf Pet Europe LLC SARL

DGAP-News: True Leaf Medicine International Ltd. / Key word(s): Merger/Strategic Company Decision True Leaf Establishes European Subsidiary True Leaf Pet Europe LLC SARL

02.08.2016 / 15:05 The issuer is solely responsible for the content of this announcement.

---------------------------------------------------------------------------

True Leaf Establishes European Subsidiary True Leaf Pet Europe LLC SARL

Vancouver, BC, August 2, 2016 - True Leaf Medicine International Ltd. (the "Company") (CSE: MJ), has established a subsidiary based in Luxembourg to conduct its business in Europe.

The subsidiary, True Leaf Pet Europe LLC SARL, was incorporated effective July 18, 2016. The Company entered into a subscription agreement to purchase 498 shares of True Leaf Pet Europe LLC SARL at a price of 25 EUR per share; the Company now holds 98% of the issued and outstanding shares of True Leaf Pet Europe LLC SARL.

Darcy Bomford, President and CEO of the True Leaf Medicine International Inc., said the establishment of a European corporation allows the Company to work in close proximity to European clients and markets. The subsidiary will work with European marketing partner Pet Horizons to build distribution networks and develop sales and distribution performance. It will also allow True Leaf to conduct business in European currency.

About True Leaf Medicine International Ltd:

True Leaf Medicine International Ltd. is entering the $104.9 billion global pet care industry with a line of hemp-focused pet chews and supplements marketed through natural pet health and veterinary channels in Canada and the US. The company has also filed an application under Health Canada's Marihuana for Medicinal Purposes Regulations (MMPR) to become a Canadian licensed producer through its 'True Leaf Medicine' subsidiary. It has passed through the preliminary and enhanced screening process of Health Canada's review and is currently awaiting security clearance and 'pre- licensing inspection' approval.

Media Contact: Paul Sullivan BreakThrough Communications O: 604-685-4742 M: 604-603-7358

www.trueleaf.com

---------------------------------------------------------------------------

02.08.2016 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement.

The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.dgap.de

---------------------------------------------------------------------------

Language: English Company: True Leaf Medicine International Ltd. 32 - 100 Kalamalka Lake Road V1T 9 G1 Vernon (BC) Canada Phone: +17783899933 E-mail: kevin@trueleaf.com Internet: www.trueleaf.com ISIN: CA89785C1077, CA89785C1077 WKN: , A0Q3EE Listed: Regulated Unofficial Market in Berlin, Munich, Stuttgart; Open Market in Frankfurt ; Canadian Venture Exchange End of News DGAP News Service ---------------------------------------------------------------------------

488653 02.08.2016